PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28986598 ↗2017Reported benefit

Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.

RatIschaemia-reperfusionOther / unspecifiedSprague-DawleyFemaleIntravitreal injection

Model: Ocular hypertension induced by episcleral vein cauterisation for 7 weeks; acute retinal ischaemic injury and optic nerve crush in vivo; retinal explants exposed to elevated hydrostatic pressure or hydrogen peroxide in vitro

Intraocular pressure elevation caused significant retinal ganglion cell loss and a threefold upregulation of the hydrogen sulfide producing enzyme 3-mercaptosulfurtransferase. GYY4137 protected retinal ganglion cells in a concentration-dependent manner in vitro and preserved cells after acute ischa…

Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.